(Q43225897)

16 November 2017

Blockade of the PD-1 pathway enhances the efficacy of adoptive cell therapy against cancer (English)

1 reference

16 November 2017

3

Patrick Hwu

1 reference

16 November 2017

Weiyi Peng

1

1 reference

16 November 2017

Gregory Lizée

series ordinal

2

1 reference

16 November 2017

language of work or name

1 reference

1 February 2013

1 reference

16 November 2017

1 reference

16 November 2017

2

1 reference

16 November 2017

2

1 reference

16 November 2017

e22691

1 reference

PD-1 blockade enhances T-cell migration to tumors by elevating IFN-γ inducible chemokines

16 November 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3601154

Effects of interferon-α-transduced tumor cell vaccines and blockade of programmed cell death-1 on the growth of established tumors

25 May 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3601154

Safety and Activity of Anti–PD-L1 Antibody in Patients with Advanced Cancer

25 May 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3601154

Safety, activity, and immune correlates of anti-PD-1 antibody in cancer

25 May 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3601154

Colocalization of inflammatory response with B7-h1 expression in human melanocytic lesions supports an adaptive resistance mechanism of immune escape

25 May 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3601154

Adoptive immunotherapy for cancer: harnessing the T cell response

25 May 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3601154

Interferon-γ-induced PD-L1 surface expression on human oral squamous carcinoma via PKD2 signal pathway

25 May 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3601154

Improved survival with vemurafenib in melanoma with BRAF V600E mutation

25 May 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3601154

25 May 2018

Identifiers

DOI

10.4161/ONCI.22691

1 reference

16 November 2017

1 reference

16 November 2017

PubMed publication ID

23524510

1 reference